Heidelberger Druck's Revenue Holds Flat as Fourth-Quarter Slowdown Raises Alarms

Heidelberger Druckmaschinen reports €2.29B sales in 2025/26, matching prior year, but a 10% Q4 slump triggers 2% stock drop. Analysts split as market awaits demand signals.

Heidelberger Druckmaschinen wrapped up its 2025/26 fiscal year with sales of €2.29 billion, matching the prior year's level exactly. But beneath that stable top line lies a jarring disconnect: a 10% revenue slump in the final quarter has soured investor sentiment and left the stock trading near the bottom of its annual range.

The fourth-quarter deceleration stands in stark contrast to the full-year steadiness. While management can point to resilience over the full twelve months, the abrupt loss of momentum in the closing period has become the central worry on the trading floor. On Tradegate, the shares slipped 2% on Thursday to €1.37, and at one point the decline reached as much as 3.29%, touching €1.351. The stock now trades barely above the lower end of its 12-month band.

Analysts are deeply split over what comes next. Warburg Research slashed its price target on May 20 from €1.70 to €1.40, a sobering revision that signals caution. By contrast, mwb research maintains a "Buy" rating with a target of €2.60, arguing that the stable full-year revenue demonstrates underlying resilience. The gap between those two assessments is unusually wide, leaving the market without a clear consensus. The average fair value stands at €2.075, implying theoretical upside of more than 50% – but that arithmetic looks less compelling when the quarterly trajectory is deteriorating.

Amid the financial uncertainty, the company continues to invest in its industrial digital printing strategy. Heidelberger Druck is integrating Plasmatreat's openair plasma technology into its Omnifire 250 and 1000 systems. The pre-treatment is designed to clean and activate surfaces before inkjet printing, improving adhesion on a variety of materials. It is a tangible bright spot in the operational story, but one that will take time to translate into revenue.

For now, the market is fixated on whether the fourth-quarter weakness was a one-off anomaly or the start of a broader slowdown. The wide gap between analyst targets reflects that uncertainty: investors are not waiting for a long-term vision, they want concrete signs that demand is stabilising again. Until those signs appear, the shares are likely to remain under pressure.